C1 esterase inhibitor concentrates and attenuated androgens

Affiliations

¹ Division of Immunology and Allergy, Department of Medical Specialties, University Hospitals and Medical Faculty, Geneva CH-1211, Switzerland. Electronic address: yannick.muller@unige.ch.
² Division of Immunology and Allergy, Department of Medical Specialties, University Hospitals and Medical Faculty, Geneva CH-1211, Switzerland.
³ Central Institute, Hospital of Valais, Sion, Switzerland.

Comment

Yannick D Muller et al. Lancet. 2018.

. 2018 Apr 7;391(10128):1355-1356.

doi: 10.1016/S0140-6736(18)30583-X.

¹ Division of Immunology and Allergy, Department of Medical Specialties, University Hospitals and Medical Faculty, Geneva CH-1211, Switzerland. Electronic address: yannick.muller@unige.ch.
² Division of Immunology and Allergy, Department of Medical Specialties, University Hospitals and Medical Faculty, Geneva CH-1211, Switzerland.
³ Central Institute, Hospital of Valais, Sion, Switzerland.

No abstract available

Comment in

C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.
Riedl MA, Relan A, Harper JR, Cicardi M. Riedl MA, et al. Lancet. 2018 Apr 7;391(10128):1356. doi: 10.1016/S0140-6736(18)30573-7. Lancet. 2018. PMID: 29636270 No abstract available.

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. Riedl MA, et al. Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25. Lancet. 2017. PMID: 28754491 Clinical Trial.